title: The safety of total hepatic vascular occlusion in rabbits with acute extrahepatic cholestasis.
abstract: The technique of normothermic total hepatic vascular occlusion (THVO) is achieved by concomitant clamping of the inferior vena cava above and below the liver in addition to portal inflow occlusion. In this study we investigated the use of THVO for 45 min in a rabbit model with acute cholestasis of 10 days' duration. In rabbits with normal preoperative liver functions (control group), serum total bilirubin, glutamic-pyruvic transaminase (SGPT), glutamic-oxaloacetic transaminase (SGOT), alkaline phosphate, and gamma-glutamyltranspeptidase levels returned to normal ranges within a week after THVO. In the group with persistent cholestasis THVO was performed 10 days after ligation of the extrahepatic bile duct. Total bilirubin and canalicular enzymes remained high while the SGOT and SGPT peaked and almost returned to the preoperative levels at 7 days following THVO in this group. A third group of animals also underwent THVO 10 days after ligation of their extrahepatic bile ducts with relief of the obstruction with a Teflon stent immediately after THVO. This group also showed the trend of normalization of liver canalicular and parenchymal enzymes and bilirubin by the end of 7 days. This study demonstrated the feasibility of THVO in rabbits with acute extrahepatic cholestasis whether the extrahepatic biliary obstruction persisted or not.
authors.affiliation: Department of General Surgery, Ankara University, Turkey.
authors.forename: S
authors.initials: S
authors.lastname: Ersöz
authors.forename: S
authors.initials: S
authors.lastname: Cakmakh
authors.forename: E
authors.initials: E
authors.lastname: Geçim
authors.forename: A G
authors.initials: AG
authors.lastname: Türkçapar
authors.forename: E
authors.initials: E
authors.lastname: Anadol
mesh_terms: D000208:Acute Disease; D000818:Animals; D001651:Cholestasis, Extrahepatic / Q000150:complications / Q000378:metabolism / Q000601:surgery*; D005500:Follow-Up Studies; D006504:Hepatic Veno-Occlusive Disease / Q000150:complications / Q000378:metabolism*; D008297:Male; D011817:Rabbits; D014682:Vena Cava, Inferior